Indian vaccine makers, Bharat Biotech and Zydus Cadila, must publish studies on the efficacy of their vaccines in relation to the Omicron variant. ZY-19489 is a potential single dose radical cure ...
Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback